MIRVASO Effective Way to Treat the Facial Redness of Rosacea
MIRVASO has been developed and clinically evaluated specifically for the treatment of the redness associated with a common skin condition called rosacea.
Fast results that last up to 12 hoursGet ready for real redness relief: MIRVASO® (brimonidine) topical gel, 0.33%* is the first and only FDA-approved medication developed and indicated for the persistent facial redness of rosacea. MIRVASO has been proven to continue to give consistent results, month after month.
MIRVASO Key Facts
MIRVASO is a temporary treatment for facial redness MIRVASO may dramatically reduce your symptoms, but it won't prevent or cure facial redness. Your redness will return after the effect of MIRVASO wears off.
This could be caused by a return of the redness to the same level it was prior to using MIRVASO, which can be concerning, especially after seeing "healthy" colored skin. Although this return of redness should go away with additional treatment, if you experience discomfort or have any concerns or questions about using MIRVASO, contact your doctor.
In clinical studies with MIRVASO, the primary endpoint showed rosacea redness was reduced for up to 12 hours for 22% of study participants (versus 9% of people using a gel with no active ingredient [vehicle gel]). The secondary endpoint‡ showed redness was visibly reduced in as little as 30 minutes for 28% of participants (versus 6% of people using the vehicle gel).